Global Excellence Seminar with Dr. Raymond Chan

  • Monday 5 February 2018 |
  • Dr. Raymond Chan |
  • MR Conference Room |
  • Time 11:00 |

Hedonic processing impairments in clinical and subclinical samples: convergent evidence from findings of self-reported, behavioural and imaging paradigms.

Schizophrenia is associated with a wide range of cognitive and emotional impairments, including the reduced ability to experience pleasure and happiness, namely anhedonia. Anhedonia is one of the key negative symptoms affecting the ultimate functional outcome and has an adverse impact on quality of life for patients with schizophrenia. Yet, very little is known about whether at-risk individuals for psychosis will also show similar deficits in experiencing pleasure and happiness. The current presentation will seek to examine the ability of experiencing pleasure in individuals at-risk for psychosis by using a 2-facet framework of anhedonia, namely the anticipatory and consummatory pleasure. Dr. Raymond Chan shall provide evidence that these at-risk individuals have already demonstrated subtle behavioural manifestations and structural brain and functional connectivity abnormalities. These findings are consistent with the impairment of the “social brain” system observed in patients with established schizophrenia and highlight the need for early identification and corresponding intervention for assisting these individuals to cope with their daily functioning. 

Dr. Raymond Chan has been conducting research actively in neuropsychology and mental health, particularly in understanding cognitive deficits in patients with schizophrenia and its underlying psychopathology. His research record has earned him the Distinguished Young Scientist Award from the National Science Foundation China, Young Investigator Award from NARSAD, and the Distinguished Griffith Visiting Researcher. He is also an elected Fellow of the Association for Psychological Science in 2017. He is the Regional Representative for Asia for the International Neuropsychological Society. He holds numerous funds from various funding agents, including the National Science Foundation of China, the Chinese Academy of Sciences, the Ministry of Science and Technology of China, NARSAD, and the Smart Futures Fund (QLD), National and International Research Alliances Program. Dr. Chan has published over 300 scientific peer-reviewed articles and 6 book chapters dealing with schizophrenia research and traumatic brain injury. He is currently serving at the editorial boards of “Schizophrenia Bulletin”, “Neuropsychology”, “Scientific Reports”, “Psychiatry Research”, “Clinical Rehabilitation”, “Cognitive Neuropsychiatry”, and “Neuropsychological Rehabilitation” and four local professional journals.

The Global Excellence Seminar will be held on Monday 5 February 2018 at 11:00 in the MR Conference Room.